Sustained abnormal CD39 activity in the pulmonary vasculature results in ATP accumulation and adenosine diminution promoting the vasoconstriction and vascular remodelling seen in PAH. The gene discussed is ENTPD1; the disease is pulmonary arterial hypertension.